# US 2003/0229119 A1 · Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0229119 A1
- Document ID: US20030229119A1
- Status: Published application
- Kind: A1
- Application number: 10/372,359
- Filed: 2003-02-21
- Published: 2003-12-11
- Earliest claimed: 2002-02-22
- Assignees: Abbott Laboratories
- Inventors: Philip R. Kym; Kresna Hartandi; Ju Gao; Kathleen M. Phelan; Irini Akritopoulou-Zanze; Christine A. Collins; Anil Vasudevan; Mary K. Verzal
- Web page: https://patentgrep.com/patent/US20030229119A1

## CPC

- C07D 215/46: with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

## Claims

### Claim 1

A compound of formula (I),
14
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—Y—A—B;
m is from 0-6;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of hydrogen, alkyl, aryl, arylC(O)—, arylS(O)2—, arylalkenyl, aryloxyalkyl, biaryl, biarylalkyl, cycloalkyl, heterocycle, heterocycleC(O)—, heterocycleS(O)2—, haloalkyl, RERFN—, RERFNC(O)—, RGS— and RGO—;
RE and RF are independently a member selected from the group consisting of hydrogen, alkyl, alkylC(O)—, aryl, arylalkyl, heterocycle, heterocyclealkyl, arylC(O)— and arylS(O)2—;
RG is a member selected from the group consisting of hydrogen, alkyl, aryl, arylalkyl and heterocycle;
Y is a member selected from the group consisting of —C(O)—, —S—, —S(O)— and —S(O)2—, or is absent;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo;
with the following provisos P1—P4:
P1 if Y is absent, m is 0 and if A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene,
then B is a member selected from the group consisting of hydrogen, alkyl, arylC(O)—, arylS(O)2—, arylalkenyl, aryloxyalkyl, biarylalkyl, cycloalkyl, heterocycle, heterocycleC(O)—, heterocycleS(O)2—, haloalkyl, RERFN—, RERFNC(O)—, RGS— and RGO—; or
P2 if Y is —C(O)—, m is 0 and A is absent,
then B is a member selected from the group consisting of hydrogen, alkyl, arylalkenyl, aryloxyalkyl, cycloalkyl, heterocycle, haloalkyl, and RERFNC(O)—; or
P3 if Y is —C(O)—, A is absent and B is aryl or heterocycle,
then m is 1-6; or
P4 if Y is —C(O)— and B is a member selected from the group consisting of arylC(O)—, arylS(O)2—, heterocycleC(O)—, heterocycleS(O)2—,
then A is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene.

### Claim 2

A compound of formula (Ia),
15
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is B;
B is heterocycle;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 3 (depends on 2)

The compound according to claim 2 selected from the group consisting of
cis-N-(2,8-bis(trifluoromethyl)quinolin-4-yl)-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(8-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(7-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(2-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(2-methylquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(2-phenylquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(6-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(6-methyl-2-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(6-fluoro-2-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(8-chloro-2-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-quinolin-4-ylcyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(5,7-dichloro-2-(trifluoromethyl)quinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3,5-difluorophenyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-phenylcyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(2-fluorophenyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3-fluorophenyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-2-naphthylcyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3-fluoro-4-methylphenyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-1-naphthylcyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3,5-dichlorophenyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3-methylphenyl)cyclohexane-1,4-diamine;
cis-N-(3,5-bis(trifluoromethyl)phenyl)-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-1,1′-biphenyl-3-yl-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3-(trifluoromethyl)phenyl)cyclohexane-1,4-diamine;
cis-4-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-2H-chromen-2-one;
cis-N,N′-bis(7-chloro-4-aminoquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-1,1′-biphenyl-3-yl-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinazolin-4-yl)-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
cis-4-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-2H-chromen-2-one;
cis-N-(7-chloroquinolin-4-yl)-N′-pyridin-2-ylcyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-isoquinolin-4-ylcyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-quinolin-3-ylcyclohexane-1,4-diamine;
(1S,2R,4S,5R)-N,N′-bis(7-chloroquinolin-4-yl)-2,5-dimethylcyclohexane-1,4-diamine;
(1S,2R,4S,5R)-N-(7-chloroquinolin-4-yl)-N′-(3,5-dimethylphenyl)-2,5-dimethylcyclohexane-1,4-diamine;
N-((1S,2R,4S,5R)-4-((7-chloroquinolin-4-yl)amino)-2,5-dimethylcyclohexyl)-3,5-difluorobenzamide;
5-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxybenzamide;
(1S,2R,4S,5R)—N,N′-bis(7-chloroquinolin-4-yl)-2,5-dimethylcyclohexane-1,4-diamine;
4-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-6-methyl-2H-chromen-2-one;
N-(7-chloroquinolin-4-yl)-N′-(2′,5-dimethyl-1,1′-biphenyl-3-yl)cyclohexane-1,4-diamine;
N-(5-bromopyridin-3-yl)-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(4-methoxy-3,5-dimethylphenyl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(5-methyl-1,1′-biphenyl-3-yl)cyclohexane-1,4-diamine;
6-(2-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-1,3-thiazol-4-yl)-3,4-dihydroquinolin-2(1H)-one;
N-(3-bromo-5-methylphenyl)-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(3-methyl-5-pyridin-4-ylphenyl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(4′,5-dimethyl-1,1′-biphenyl-3 yl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(3′,5-dimethyl-1,1′-biphenyl-3-yl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(4-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-1,3-thiazol-2-yl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(4-methyl-5-phenyl-1,3-thiazol-2-yl)cyclohexane-1,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(5-phenylpyridin-3-yl)cyclohexane-1,4-diamine;
3′-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-5′-methyl-1,1′-biphenyl-4-ol;
N′-{4-((2-N-methylamino-7-chloroquinolin-4-yl)amino)cyclohexyl}-7-chloro-N-methylquinoline-2,4-diamine;
N-(7-chloroquinolin-4-yl)-N′-(4-(4-methoxyphenyl)-1,3-thiazol-2-yl)cyclohexane-1,4-diamine; and
N-(7-chloroquinolin-4-yl)-N′-(4,5-dimethyl-1,3-thiazol-2-yl)cyclohexane-1,4-diamine.

### Claim 4

A compound that is cis-N-(7-chloroquinolin-4-yl)-N′-(3,5-dimethylphenyl)cyclohexane-1,4-diamine.

### Claim 5

A compound of formula (Ib),
16
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —A—B;
A is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is heterocycle;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 6 (depends on 5)

The compound according to claim 5 selected from the group consisting of
cis-N-(7-chloroquinolin-4-yl)-N′-(quinolin-3-ylmethyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(quinolin-4-ylmethyl)cyclohexane-1,4-diamine;
cis-N-(4-bromobenzyl)-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-{(4-(dimethylamino)-1-naphthyl)methyl} cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(4-pyridin-2-ylbenzyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(1H-indol-6-ylmethyl)cyclohexane-1,4-diamine;
cis-N-(4,4-bis(4-fluorophenyl)butyl)-N′-(7-chloroquinolin-4-yl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(4-phenylbutyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(5-phenylpentyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3,5-difluorobenzyl)cyclohexane-1,4-diamine;
cis-N-(7-chloroquinolin-4-yl)-N′-(3-fluorobenzyl)cyclohexane-1,4-diamine; and
cis-7-chloro-N-4-(4-{(3-(trifluoromethyl)benzyl)amino} cyclohexyl)quinoline-2,4-diamine.

### Claim 7

A compound according to formula (Ic)
17
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—C(O)—A—B;
m is from 0-6;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of hydrogen, alkyl, aryl, arylC(O)—, arylS(O)2—, arylalkenyl, aryloxyalkyl, biaryl, biarylalkyl, cycloalkyl, heterocycle, heterocycleC(O)—, heterocycleS(O)2—, haloalkyl, RERFN—, RERFNC(O)—, RGS— and RGO—;
RE and RF are each independently a member selected from the group consisting of hydrogen, alkyl, alkylC(O)—, aryl, arylalkyl, heterocycle, heterocyclealkyl, arylC(O)— and arylS(O)2—;
RG is a member selected from the group consisting of hydrogen, alkyl, aryl, arylalkyl and heterocycle;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 8 (depends on 7)

The compound according to claim 7, wherein
m is 0; and
A is absent.

### Claim 9 (depends on 7)

The compound according to claim 7, wherein
m is 0;
A is absent; and
B is a member selected from the group consisting of aryl, arylalkenyl, aryloxyalkyl, biaryl and heterocycle.

### Claim 10 (depends on 9)

The compound according to claim 9 selected from the group consisting of
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1H-indole-6-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-methylbenzamide;
cis-2-amino-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-hydroxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-methoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluorobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-fluorobenzamide;
cis-4-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-2-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-3-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-4-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}}benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-cyanobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(dimethylamino)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-cyanobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(dimethylamino)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(trifluoromethyl)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(trifluoromethyl)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,3-dimethylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,4-dimethylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(trifluoromethoxy)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,5-dimethylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,4-dimethylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,4-dimethoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,4-dimethoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,5-dimethoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1,3-benzodioxole-5-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,4,5-trimethoxybenzamide;
cis-2,4-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-3,4-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-furamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-furamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,5-dimethyl-3-furamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}thiophene-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}thiophene-3-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methylthiophene-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1H-pyrrole-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,5-dimethylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-methylthiophene-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,5-dimethyl-1H-pyrrole-3-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1,2,5-trimethyl-1H-pyrrole-3-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1,3-thiazole-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1-methyl-1H-pyrrole-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1,3-thiazole-4-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1,3-thiazole-5-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}isoxazole-5-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-methyl-3-phenylisoxazole-4-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}pyridine-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-hydroxypyridine-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxynicotinamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-methylpyrazine-2-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1H-indole-3-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-8-methyl-4-oxo-4H-pyrido(1,2-a)pyrimidine-3-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-methyl-1-phenyl-1H-pyrazole-4-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide;
cis-6-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2H-chromene-3-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-ethylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-4-methylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-hydroxy-4-methylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-2-methylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluoro-4-methylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,3-difluorobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,4-difluorobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,5-difluorobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,5-difluorobenzamide;
cis-4-acetyl-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methoxy-4-methylbenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-ethoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(methylthio)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluoro-4-methoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-naphthamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1-naphthamide;
cis-5-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxybenzamide;
cis-2-(acetylamino)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-4-(acetylamino)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-isopropoxybenzamide;
cis-5-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-fluoro-1-naphthamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,4-diethoxybenzamide;
cis-2-benzyl-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(2-phenylethyl)benzamide;
cis-2-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-methoxybenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(4-methylbenzoyl)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-iodobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-iodobenzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-iodobenzamide;
cis-2-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}isonicotinamide;
cis-2-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-6-methylisonicotinamide;
cis-2,6-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}isonicotinamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-phenoxybutanamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(3-methyl-1H-indol-1-yl)propanamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(1-methyl-1H-benzimidazol-2-yl)propanamide;
cis-1-benzoyl-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}piperidine-4-carboxamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(4-propoxyphenyl)urea;
cis-N-(5-tert-butyl-2-methoxyphenyl)-N′-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}urea;
cis-3,5-difluoro-N-(4-{(6-fluoro-2-(trifluoromethyl)quinolin-4-yl)amino} cyclohexyl)benzamide;
cis-3,5-difluoro-N-(4-{(8-(trifluoromethoxy)-2-(trifluoromethyl)quinolin-4-yl)amino} cyclohexyl)benzamide;
cis-N-(4-{(5,7-dichloro-2-(trifluoromethyl)quinolin-4-yl)amino} cyclohexyl)-3,5-difluorobenzamide;
cis-3,5-difluoro-N-(4-{(6-methyl-2-(trifluoromethyl)quinolin-4-yl)amino} cyclohexyl)benzamide;
cis-N-{4-((2-amino-7-chloroquinolin-4-yl)amino)cyclohexyl}-3,5-difluorobenzamide;
cis-N-{4-((2-amino-7-chloroquinolin-4-yl)amino)cyclohexyl}-3,5-dichlorobenzamide;
cis-N-{4-((2-amino-7-chloroquinolin-4-yl)amino)cyclohexyl}-4-phenoxybutanamide;
3-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluorobenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-5-methylbenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,2-diphenylacetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-2-hydroxybenzamide;
N-{(1S,2R,4S,5R)-4-((7-chloroquinolin-4-yl)amino)-2,5-dimethylcyclohexyl}-3,5-difluorobenzamide;
3-(5-acetylthien-2-yl)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluorobenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-5-methoxybenzamide;
4-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxybenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}quinoline-3-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-3-methylbenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,6-dimethoxynicotinamide;
3-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluorobenzamide;
3′-amino-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-1,1′-biphenyl-3-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-3′-hydroxy-1,1′-biphenyl-3-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-3′-(hydroxymethyl)-1,1′-biphenyl-3-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-4′-hydroxy-1,1′-biphenyl-3-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1H-indole-4-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}quinoxaline-2-carboxamide;
4′-amino-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-1,1′-biphenyl-3-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-4-methoxybenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}cinnoline-4-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-6-methoxybenzamide;
3′-acetyl-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-1,1′-biphenyl-3-carboxamide;
5-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-3-methylbenzamide;
3-(1,3-benzodioxol-5-yl)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluorobenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-2′-hydroxy-1,1′-biphenyl-3-carboxamide;
4′-acetyl-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-1,1′-biphenyl-3-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-6-methylnicotinamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluoro-5-pyridin-4-ylbenzamide;
2-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}nicotinamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-5-iodobenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-fluoro-6-hydroxybenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluoro-5-thien-3-ylbenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluoro-5-((E)-2-phenylvinyl)benzamide;
3-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxybenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluoro-5-thien-2-ylbenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-8-hydroxyquinoline-7-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-1-naphthamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-3-isopropylbenzamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-hydroxy-2-naphthamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}tetrahydrofuran-2-carboxamide;
3′-(({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)carbonyl)-5′-fluoro-1,1′-biphenyl-3-carboxylic acid;
3′-(({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)carbonyl)-5′-fluoro-1,1′-biphenyl-4-carboxylic acid; and
7-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-hydroxyquinoline-3-carboxamide.

### Claim 11

A compound of formula (Id),
18
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—C(O)—A—B;
m is 0;
A is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of arylC(O)—, arylNC(O)—, arylS(O)2—, heterocycleC(O)—, heterocycleNC(O)— and heterocycleS(O)2—;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 12 (depends on 11)

The compound according to claim 11 selected from the group consisting of
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-oxo-4-thien-2-ylbutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(phenylsulfonyl)propanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(4-methoxyphenyl)-4-oxobutanamide; and
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-oxo-4-phenylbutanamide.

### Claim 13

A compound of formula (Ie),
19
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—C(O)—A—B;
m is from 1-6;
A is absent;
B is a member selected from the group consisting of aryl and heterocycle;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 14 (depends on 13)

The compound according to claim 13 selected from the group consisting of
cis-2-(N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}glycyl)benzaldehyde;
cis-di-3-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-1-(4-fluorophenyl)propan-1-one; and
cis-5-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-1-(4-fluorophenyl)pentan-1-one.

### Claim 15

A compound of formula (If),
20
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—C(O)—A—B;
m is 0;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of aryl and heterocycle;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 16 (depends on 23)

The compound according to claim 23 selected from the group consisting of
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(4-fluorophenyl)acetamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-phenylpentanamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(6-methoxy-3-oxo-2,3-dihydro-1H-inden-1-yl)acetamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(3-fluorophenyl)acetamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(3-(trifluoromethyl)phenyl)acetamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(4-(trifluoromethyl)phenyl)acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methyl-2-phenylpentanamide;
(2R)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methoxy-2-phenylacetamide;
(2S)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methoxy-2-phenylacetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(3,5-difluorophenyl)acetamide;
3-(2-chlorophenyl)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}propanamide;
(2S)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-phenylbutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-phenylpropanamide;
3-(4-chlorophenyl)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}propanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(2,5-dimethoxyphenyl)propanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-thien-2-ylbutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-phenylbutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(4-methoxyphenyl)propanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(3-methoxyphenyl)propanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(3-phenoxyphenyl)acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(4-(methylsulfonyl)phenyl)acetamide; and
(2R)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-hydroxy-4-phenylbutanamide.

### Claim 17

A compound of formula (Ig),
21
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)mC(O)—A—B;
m is from 0-6;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is RERFN—;
RE and RF are independently a member selected from the group consisting of hydrogen, alkyl, alkylC(O)—, aryl, arylalkyl, heterocycle, heterocyclealkyl, arylC(O)— and arylS(O)2—;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 18 (depends on 17)

The compound according to claim 17 wherein
RE is a member selected from the group consisting of alkylC(O)—, arylC(O)— and arylS(O)2—;
m is 0; and
A is alkylene.

### Claim 19 (depends on 18)

The compound according to claim 18 selected from the group consisting of
cis-N2-benzoyl-N1-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}glycinamide
cis-N1-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N3-(4-nitrobenzoyl)-β-alaninamide;
cis-N3-benzoyl-N′-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl)}-β-alaninamide;
N-(2-({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)-2-oxo-1-ethyl)-2-hydroxybenzamide;
N-2-acetyl-N-1-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-L-leucinamide; and
N-1-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N-2-((4-methylphenyl)sulfonyl)glycinamide.

### Claim 20 (depends on 17)

The compound according to claim 17, wherein
B is RERFN—;
RE is a member selected from the group consisting of aryl, arylalkyl, heterocycle and heterocyclealkyl;
m is 0; and
A is absent.

### Claim 21 (depends on 20)

The compound according to claim 20 selected from the group consisting of
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(3-(methylthio)phenyl)urea;
cis-N-(2-chlorophenyl)-N′-4-((7-chloroquinolin-4-yl)amino)cyclohexyl}urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(2-(trifluoromethyl)phenyl)urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(3-(trifluoromethyl)phenyl)urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(4-(trifluoromethyl)phenyl)urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(4-(trifluoromethoxy)phenyl)urea;
cis-N-1,3-benzodioxol-5-yl-N′-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-{3-((trifluoromethyl)thio)phenyl}urea;
cis-N-(3-bromophenyl)-N′-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}urea;
cis-N-(4-bromophenyl)-N′-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(3,4-dichlorophenyl)urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(2,4-dichlorophenyl)urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(3,5-dichlorophenyl)urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-1-naphthylurea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-2-naphthylurea;
cis-N-benzyl-N′-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}urea;
cis-N-(3-chlorophenyl)-N′-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}urea;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(2-furylmethyl)urea; and
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-(3-furylmethyl)urea.

### Claim 22

A compound of formula (Ih),
22
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—C(O)—A—B;
m is from 0-6;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is RERFNC(O)—;
RE and RF are independently a member selected from the group consisting of hydrogen, alkyl, alkylC(O)—, aryl, arylalkyl, heterocycle, heterocyclealkyl, arylC(O)— and arylS(O)2—;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 23 (depends on 22)

The compound according to claim 22, wherein
RE is a member selected from the group consisting of aryl, arylalkyl, heterocycle and heterocyclealkyl;
m is 0; and
A is alkylene.

### Claim 24 (depends on 23)

The compound according to claim 23 that is
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-N′-phenylpentanediamide.

### Claim 25

A compound of formula (Ij),
23
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—C(O)—A—B;
m is from 0-6;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of RGS— and RGO—;
RG is a member selected from the group consisting of hydrogen, alkyl, aryl, arylalkyl, heterocycle and heterocyclealkyl;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 26 (depends on 25)

The compound according to claim 25, wherein
RG is a member selected from the group consisting of alkyl, aryl, arylalkyl, heterocycle and heterocyclealkyl;
m is 0; and
A is alkylene.

### Claim 27 (depends on 26)

The compound according to claim 26 selected from the group consisting of
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-((4-methylpyrimidin-2-yl)thio)acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(3-methoxyphenoxy)acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(3-methylphenoxy)acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(2-methylphenoxy)acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-phenoxypropanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(3,4-dimethylphenoxy)acetamide;
2-(4-chloro-2-methylphenoxy)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}acetamide;
2-(benzyloxy)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-ethoxyacetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(pyrimidin-2-ylthio)acetamide; and
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(4-methylphenoxy)acetamide.

### Claim 28

A compound of formula (Ik),
24
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—C(O)—A—B;
m is 0;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of alkyl, cycloalkyl and haloalkyl;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 29 (depends on 28)

The compound according to claim 28 selected from the group consisting of
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-cyclohexylacetamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-cycloheptylacetamide;
cis-2-((1R,4S)-bicyclo(2.2.1)hept-2-yl)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}acetamide;
cis-2-(1-adamantyl)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}acetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-methylpentanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}pentanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}hexanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}cyclopentanecarboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-cyclopentylacetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methylcyclohexanecarboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}cycloheptanecarboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methylcyclohexanecarboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-methylcyclohexanecarboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methylbutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}cyclohexanecarboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methylpentanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4,4,4-trifluorobutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}heptanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}butanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-cyclopropylacetamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,2-dimethylpropanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-ethylbutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1-phenylcyclopropanecarboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,3-dimethylbutanamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}adamantane-1-carboxamide;
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methylpentanamide; and
N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1-methylcyclohexanecarboxamide.

### Claim 30

A compound of formula (Im),
25
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—S(O)2-A-B;
m is from 0-6;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of alkyl, aryl, arylalkenyl, cycloalkyl and heterocycle;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 31 (depends on 30)

The compound according to claim 30, wherein
m is 0;
A is absent; and
B is a member selected from the group consisting of aryl and heterocycle.

### Claim 32 (depends on 31)

The compound according to claim 31 selected from the group consisting of
cis-4-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-2-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-fluorobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}thiophene-2-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(trifluoromethoxy)benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methylbenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-methylbenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-fluorobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-fluorobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-fluorobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-cyanobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-cyanobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-cyanobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,5-dimethylbenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methoxybenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-methoxybenzenesulfonamide;
cis-2-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-3-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-4-(2-chloro-6-nitrophenoxy)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,4-difluorobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,4-difluorobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-propylbenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-isopropylbenzenesulfonamide;
cis-4-chloro-N-({5-(({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)sulfonyl)thien-2-yl} methyl)benzamide;
cis-5-bromo-6-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}pyridine-3-sulfonamide;
cis-4-tert-butyl-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzene sulfonamide;
cis-3-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-fluorobenzenesulfonamide;
cis-N-{4-(({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)sulfonyl)phenyl} acetamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,5-dimethoxybenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,4-dimethoxybenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(trifluoromethyl)benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(trifluoromethyl)benzenesulfonamide;
cis-2,3-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzene sulfonamide;
cis-2,4-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-2,5-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-3,4-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-3,5-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1,1′-biphenyl-4-sulfonamide;
cis-2-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-3-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-4-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(trifluoromethoxy)benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,5-dimethylisoxazole-4-sulfonamide;
cis-(E)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-phenylethylenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-vinylbenzenesulfonamide;
cis-5-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}thiophene-2-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,1,3-benzoxadiazole-4-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-nitrobenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-nitrobenzenesulfonamide;
cis-3-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-methylbenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}quinoline-8-sulfonamide;
cis-5-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1,3-dimethyl-1H-pyrazole-4-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,1,3-benzothiadiazole-4-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methyl-5-nitrobenzenesulfonamide;
cis-methyl 3-(({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)sulfonyl)thiophene-2-carboxylate;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(1,1-dimethylpropyl)benzenesulfonamide;
cis-4-butoxy-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-isoxazol-3-ylthiophene-2-sulfonamide;
cis-2,5-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}thiophene-3-sulfonamide;
cis-4,5-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}thiophene-2-sulfonamide;
cis-7-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2,1,3-benzoxadiazole-4-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(methylsulfonyl)benzenesulfonamide;
cis-4-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-nitrobenzenesulfonamide;
cis-6-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3H—I lambda-4-imidazo(2,1-b)(1,3)thiazole-5-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-(trifluoroacetyl)-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-fluoro-2-methylbenzenesulfonamide;
cis-4-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-(triflu oromethyl)benzenesulfonamide;
cis-2,4,5-trichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-2,4,6-trichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-2,3,4-trichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-5-chloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3-methyl-1-benzothiophene-2-sulfonamide;
cis-5-bromo-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methoxybenzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-nitro-4-(trifluoromethyl)benzenesulfonamide;
cis-N-({5-(({4-((7-chloroquinolin-4-yl)amino)cyclohexyl}amino)sulfonyl)thien-2-yl}methyl)benzamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-(2-(methylthio)pyrimidin-4-yl)thiophene-2-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-3,5-bis(trifluoromethyl)benzenesulfonamide;
cis-2,6-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-(trifluoromethyl)benzenesulfonamide;
cis-2-butoxy-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-(1,1-dimethylpropyl)benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-5-(phenylsulfonyl)thiophene-2-sulfonamide;
cis-4-(3-chloro-2-cyanophenoxy)-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}benzenesulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-4-ethylbenzenesulfonamide;
cis-4-bromo-2,5-dichloro-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}thiophene-3-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-methoxy-5-methylbenzenesulfonamide; and
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-2-nitrobenzenesulfonamide.

### Claim 33 (depends on 30)

The compound according to claim 30 wherein
m is 0;
A is alkylene; and
B is a member selected from the group consisting of aryl and heterocycle.

### Claim 34 (depends on 33)

The compound according to claim 33 selected from the group consisting of
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1-(3,4-dichlorophenyl)methanesulfonamide; and
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1-(3,5-dichlorophenyl)methanesulfonamide.

### Claim 35 (depends on 30)

The compound according to claim 30, wherein
m is 0;
A is alkylene; and
B is a member selected from the group consisting of alkyl and cycloalkyl.

### Claim 36 (depends on 35)

The compound according to claim 35 selected from the group consisting of
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}propane-1-sulfonamide;
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}butane-1-sulfonamide; and
cis-N-{4-((7-chloroquinolin-4-yl)amino)cyclohexyl}-1-((1S,4R)-7,7-dimethyl-2-oxobicyclo(2.2.1)hept-1-yl)methanesulfonamide.

### Claim 37

A method of treating disorders by inhibiting the effects of melanin concentrating hormone (MCH) through the melanin concentrating hormone receptor, comprising administrering a therapeutically effective amount of a compound of formula (II),
26
or a therapeutically suitable salts, ester, prodrug or zwitterion thereof, wherein
R1, R2 and R3 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy, hydroxy and RARBN— wherein RA and RB are each independently a member selected from the group consisting of hydrogen and alkyl, alkylcarbonyl, alkylsulfonyl, arylcarbonyl, arylsulfonyl and RCRDNcarbonyl, wherein RC and RD are each independently a member selected from the group consisting of hydrogen, alkyl and aryl;
R4 is a member selected from the group consisting of hydrogen and alkyl;
R5 is —(CH2)m—Y-A-B;
m is from 0-6;
A is absent or is a member selected from the group consisting of alkoxyalkylene, alkylene and hydroxyalkylene;
B is a member selected from the group consisting of hydrogen, alkyl, aryl, arylC(O)—, arylS(O)2—, arylalkenyl, aryloxyalkyl, biaryl, biarylalkyl, cycloalkyl, heterocycle, heterocyclcC(O)—, heterocycleS(O)2—, haloalkyl, RERFN—, RERFNC(O)—, RGS— and RGO—;
RE and RF are each independently a member selected from the group consisting of hydrogen, alkyl, alkylC(O)—, aryl, arylalkyl, heterocycle, heterocyclealkyl, arylC(O)— and arylS(O)2—;
RG is a member selected from the group consisting of hydrogen, alkyl, aryl, arylalkyl and heterocycle;
Y is a member selected from the group consisting of —C(O)—, —S—, —S(O)— and —S(O)2—, or is absent;
R6 is a member selected from the group consisting of hydrogen, alkyl and arylcarboxyalkyl; and
R7, R8, R9, and R10 are each independently a member selected from the group consisting of hydrogen, alkyl, alkoxy, halo, haloalkyl, haloalkoxy and hydroxy or R7 and R8 taken together with the carbon atom that they are attached form oxo.

### Claim 38

A method of treating obesity by inhibiting the effects of melanin concentrating hormone (MCH) through the melanin concentrating hormone receptor, comprising administrering a therapeutically effective amount of a compound of formula (II).

### Claim 39

A method of treating abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping and arousal, anxiety and depression, seizure and in treatment of neurodegeneration or psychiatric disorders by inhibiting the effects of melanin concentrating hormone (MCH) through the melanin concentrating hormone receptor, comprising administrering a therapeutically effective amount of a compound of formula (II).

### Claim 40

A pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (II) in combination with a pharmaceutically suitable carrier.
